ConductScience.org, home

Paper1698529

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin.

Sadek H and 8 others. Cancer, 1990. Cited by 130 papers, by iCite.

Cite this record

ConductScience Library. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Papers, record 1698529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1698529

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin.
PubMed
Journal
Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
3.87
iCite
Revised in PubMed
2022-03-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sadek HH
2Azli NN
3Wendling JLJ L
4Cvitkovic EE
5Rahal MM
6Mamelle GG
7Guillaume JCJ C
8Armand JPJ P
9Avril MFM F

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Carcinoma, Squamous CellMajor topic
Lip NeoplasmsMajor topic
Skin NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Bleomycin
Child
Cisplatin
Combined Modality Therapy
Female
Fluorouracil
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
41514559Systemic Chemotherapy in Penile Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Evidence-Based Regimens.Cancers (Basel)2025https://conductscience.org/library/papers/41514559PubMed
41252099Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma.Am J Clin Dermatol2026https://conductscience.org/library/papers/41252099PubMed
41228268Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients.Cancers (Basel)2025https://conductscience.org/library/papers/41228268PubMed
40405694Cetuximab plus 5-fluorouracil in patients with advanced cutaneous squamous cell carcinoma: a retrospective cohort study.J Dtsch Dermatol Ges2025https://conductscience.org/library/papers/40405694PubMed
39682109The Role of Radiation, Immunotherapy, and Chemotherapy in the Management of Locally Advanced or Metastatic Cutaneous Malignancies.Cancers (Basel)2024https://conductscience.org/library/papers/39682109PubMed
38500295Neoadjuvant Chemotherapy Alone or Combined with EGFR-Directed Targeted Therapy or Anti-PD-1 Immunotherapy for Locally Advanced Lacrimal Sac and Nasolacrimal Duct Carcinomas.Semin Ophthalmol2024https://conductscience.org/library/papers/38500295PubMed
37780565Treatment of metastatic squamous cell carcinoma arising in sacrococcygeal pilonidal sinus: a case report series.Front Med (Lausanne)2023https://conductscience.org/library/papers/37780565PubMed
37747408Squamous cell carcinoma of the eyelid.Jpn J Clin Oncol2024https://conductscience.org/library/papers/37747408PubMed
37686588Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre.Cancers (Basel)2023https://conductscience.org/library/papers/37686588PubMed
37370790Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.Cancers (Basel)2023https://conductscience.org/library/papers/37370790PubMed
36991168Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.Ann Surg Oncol2023https://conductscience.org/library/papers/36991168PubMed
36329570Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: A systemic review and meta-analysis.Skin Res Technol2023https://conductscience.org/library/papers/36329570PubMed
35954316Advances in Cutaneous Squamous Cell Carcinoma Management.Cancers (Basel)2022https://conductscience.org/library/papers/35954316PubMed
35760499Metastatic insidious super giant basal cell carcinoma.BMJ Case Rep2022https://conductscience.org/library/papers/35760499PubMed
35158818Recent Advanced in the Treatment of Advanced SCC Tumors.Cancers (Basel)2022https://conductscience.org/library/papers/35158818PubMed
35070956Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives.Front Oncol2021https://conductscience.org/library/papers/35070956PubMed
34877077Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma.Dermatol Pract Concept2021https://conductscience.org/library/papers/34877077PubMed
34842930Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany.Acta Derm Venereol2022https://conductscience.org/library/papers/34842930PubMed
34195900High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review.Ann Surg Oncol2021https://conductscience.org/library/papers/34195900PubMed
34122442Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.Front Immunol2021https://conductscience.org/library/papers/34122442PubMed

See all 52 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1698529

GET https://conductscience.org/api/papers/v1/1698529/cited_by?page=2